Pfizer, BioNTech Say COVID-19 Vaccine Might Be Ready by End of October

Currently, Pfizer and Germany’s BioNTech appear to be leading in the race to get a COVID-19 vaccine approved. In a weekend interview on CBS’ “Face the Nation,” Albert Bourla, chief executive officer of Pfizer indicated they may have key data from its Phase III trial of the vaccine to the U.S. Food and Drug Administration (FDA) by the end of October. If it is then approved, he said they would be prepared to distribute “hundreds of thousands of doses.”